Rich Simoni
Managing Partner @ Asset Management Ventures (AMV)
Palo Alto, United States
Rich Simoni is a Series A investor at Asset Management Ventures (AMV) in Palo Alto focused on Software and CRM. Rich joined Asset Management Company in 2002. He combines a deep technical background with extensive operational business experience. Over the past 20 years he has been involved with numerous start-up companies, in both management and consulting roles. Prior to joining the firm in 2002, he co-founded Talkway Communications, a provider of internetvideo services such as video email to major providers including AT&T and British Telecom.Two of his academic publications were chosen for inclusion in the 25-year retrospective of the International Symposium on Computer Architecture, the premier conference in the computer architecture field. He is an expert in distributed computing, performance measurement and optimization, scalable computing, internet protocols and architectures, digital audio and video, and wireless computing.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Rich Simoni invests in
Stages Rich Simoni invests in
Countries Rich Simoni invests in
Investment Focus
Stage
- Series A 3 (27%)
- Series B 2 (18%)
- Funding Round 2 (18%)
- Seed 1 (9%)
- Series C 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Properly
|
Properly is a visual checklist tool that lets property owners share turnover instructions with cleaning pros effortlessly.Properly's mission is to have hosts and property managers get the same streamlined results during every guest turnover cleaning, and for professional cleaners to understand their clients' expectations and getrecognized for stellar work. | $8.5M / Series A / Oct 29, 2018 | |
Twist Bioscience
|
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries. It produces synthetic DNA used in applications across healthcare, agriculture, industrial chemicals, and data storage. The company develops a silicon-based DNA synthesis platform to enable high-throughput, scalable, and preciseDNA production. Its technology supports research and development in drug discovery and specialty chemical production. | $33M / Mar 27, 2017 | |
Womply
|
Our mission is to help local businesses thrive in a digital world. Founded in 2011, Womply is a local commerce platform that provides apps, APIs, marketing, and financial tools to make local commerce happen for over 500,000 American businesses and their customers. All of Womply’s products and services are powered by the Womply Commerce Graph, aproprietary data asset that offers the most complete view of local commerce. | $30M / Series B / Nov 15, 2016 | |
|
Twist Bioscience
|
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries. It produces synthetic DNA used in applications across healthcare, agriculture, industrial chemicals, and data storage. The company develops a silicon-based DNA synthesis platform to enable high-throughput, scalable, and preciseDNA production. Its technology supports research and development in drug discovery and specialty chemical production. | $61M / Series D / Jan 19, 2016 | |
|
Twist Bioscience
|
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries. It produces synthetic DNA used in applications across healthcare, agriculture, industrial chemicals, and data storage. The company develops a silicon-based DNA synthesis platform to enable high-throughput, scalable, and preciseDNA production. Its technology supports research and development in drug discovery and specialty chemical production. | $37M / Series C / Jun 09, 2015 | |
|
Womply
|
Our mission is to help local businesses thrive in a digital world. Founded in 2011, Womply is a local commerce platform that provides apps, APIs, marketing, and financial tools to make local commerce happen for over 500,000 American businesses and their customers. All of Womply’s products and services are powered by the Womply Commerce Graph, aproprietary data asset that offers the most complete view of local commerce. | $20M / Aug 01, 2014 | |
|
Twist Bioscience
|
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries. It produces synthetic DNA used in applications across healthcare, agriculture, industrial chemicals, and data storage. The company develops a silicon-based DNA synthesis platform to enable high-throughput, scalable, and preciseDNA production. Its technology supports research and development in drug discovery and specialty chemical production. | $26M / Series B / May 27, 2014 | |
|
Twist Bioscience
|
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries. It produces synthetic DNA used in applications across healthcare, agriculture, industrial chemicals, and data storage. The company develops a silicon-based DNA synthesis platform to enable high-throughput, scalable, and preciseDNA production. Its technology supports research and development in drug discovery and specialty chemical production. | $9.1M / Series A / Feb 10, 2014 | |
|
Womply
|
Our mission is to help local businesses thrive in a digital world. Founded in 2011, Womply is a local commerce platform that provides apps, APIs, marketing, and financial tools to make local commerce happen for over 500,000 American businesses and their customers. All of Womply’s products and services are powered by the Womply Commerce Graph, aproprietary data asset that offers the most complete view of local commerce. | Jan 01, 2014 | |
Keepsafe
|
Keepsafe makes privacy in the digital world as easy as it is in the physical world. For consumers who want ownership over their digital privacy and a simple way to manage it, Keepsafe’s suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, let you keep personal items private and share them safely. It’s a hub for all of yourmost important things. | $3.4M / Series A / Jul 16, 2013 | |
| See all 11 investments → | |||
Co-Investors
About Asset Management Ventures (AMV)
AMV is a venture capital firm investing in early-stage digital health, tech, and life sciences companies.
Asset Management Ventures (AMV) Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Louis Lange
Partner
|
|||
|
Rich Simoni
Managing Partner
|
|||
Skip Fleshman
Partner
|
|||
|
Pitch Johnson
Founder
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Rich Simoni invest in?
Rich Simoni invests primarily in Software, CRM and Apps startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Rich Simoni last invest?
The most recent investment recorded for Rich Simoni closed in Oct 2018. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
